Home » Topics » BioWorld Science

BioWorld Science
RSS

Gain-of-function p.Glu1099Lys variant in the NSD2 gene tied to novel syndrome

June 15, 2022

Merck KGaA collaborates with University of Bonn on tools for computational chemistry modeling

June 15, 2022

T3SS inhibitor MBX-5452 well tolerated and reduces bacterial load in pneumonia mouse model

June 15, 2022

ADGRL1 haploinsufficiency linked to neurodevelopmental disorders

June 15, 2022

Aqilion receives clearance for phase I study of AQ-280 for eosinophilic esophagitis

June 15, 2022

National Center for Geriatrics & Gerontology synthesizes acyclic retinoid derivatives

June 15, 2022

A&J Science synthesizes new antibacterials

June 15, 2022

Beijing Jacobio Pharmaceuticals identifies new GTPase KRAS inhibitors

June 15, 2022

Deciphera Pharmaceuticals discloses PERK and/or GCN2 inhibitors

June 15, 2022

Vanderbilt University patents new muscarinic M4 receptor antagonists

June 15, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...